Rating Change
Jefferies analysts upgraded Minerva Neurosciences, Inc. (NASDAQ:NERV) from Hold to Buy on August 14, 2026.
upgradeNASDAQ:NERV
Minerva Neurosciences, Inc. (NERV) Upgraded to Buy at Jefferies
Jefferies analysts upgraded Minerva Neurosciences, Inc. (NASDAQ:NERV) from Hold to Buy on August 14, 2026.
At publication ·
What changed
Minerva Neurosciences, Inc. (NASDAQ:NERV) · upgrade
- Firm
- Jefferies
- Rating
- Hold to Buy
- Price at event
- $4.58
- Market capitalization
- $29.0M
At a glance
Key takeaways
- Jefferies upgraded Minerva Neurosciences (NERV) from Hold to Buy on August 14, 2026, suggesting analysts see improving fundamentals or favorable risk-reward dynamics.
Market Context
Minerva Neurosciences, Inc. operates in the Healthcare sector. The stock currently trades at $4.58 with a market capitalization of $29.0M. The stock has gained 153.0% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Jefferies's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Minerva Neurosciences, Inc.
Among the 10 most recent ratings: 2 Buy, 8 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Jefferies | Buy | N/A |
| Apr 15, 2026 | Citizens | Market Outperform | N/A |
| Mar 12, 2026 | HC Wainwright & Co. | Neutral | N/A |
| Nov 06, 2025 | HC Wainwright & Co. | Neutral | N/A |
| Feb 26, 2025 | HC Wainwright & Co. | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View NERV Stock Page
Frequently Asked Questions
What does the Buy rating mean for NERV?
A rating of Buy from Jefferies reflects the analyst's outlook on Minerva Neurosciences, Inc. (NASDAQ:NERV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NERV forecast page.